<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-24T14:12:49Z</responseDate><request verb="GetRecord" identifier="oai:repository.ajou.ac.kr:201003/11871" metadataPrefix="oai_dc">https://repository.ajou.ac.kr/oai/request</request><GetRecord><record><header><identifier>oai:repository.ajou.ac.kr:201003/11871</identifier><datestamp>2024-10-11T02:21:24Z</datestamp><setSpec>com_201003_14369</setSpec><setSpec>com_201003_14368</setSpec><setSpec>col_201003_14370</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Prognostic significance of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma</dc:title>
<dc:title>비전이 투명 신세포암 환자의 수술 전 호중구/림프구 비율과 혈소판/림프구 비율의 예후적 중요도</dc:title>
<dc:creator>이, 정환</dc:creator>
<dc:contributor>김, 선일</dc:contributor>
<dc:contributor>대학원 의학과</dc:contributor>
<dc:contributor>201224382</dc:contributor>
<dc:contributor>이, 정환</dc:contributor>
<dc:subject>Renal cell carcinoma</dc:subject>
<dc:subject>systemic inflammation</dc:subject>
<dc:subject>prognosis</dc:subject>
<dc:subject>신장암</dc:subject>
<dc:subject>염증</dc:subject>
<dc:subject>예후 인자</dc:subject>
<dc:description>Introduction &amp; Objectives: This study was performed to evaluate the significance of preoperative neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as a predictive factor for recurrence in patients with non-metastatic clear cell renal cell carcinoma (RCC). 

Material &amp; Methods: We retrospectively reviewed the medical records of 341 patients (232 men and 109 women, mean age of 54.9 years) with non-metastatic clear cell RCC who underwent radical or partial nephrectomy between March 1995 and July 2012. Patients longer than 12 months follow-up were included. The prognostic significance of various clinicopathological variables for recurrence-free survival and cancer specific-free survival was analyzed by using univariate and multivariate analysis. 

Results: The median follow-up duration was 48 months (mean, 54.1; range, 12-215 months). Of the total 341 patients, 37 patients (10.9%) developed metastases and 14 patients (4.1%) died of renal cell carcinoma among 21 patients who died during the follow-up period. Preoperative NLR was significantly correlated with symptom presentation (p=0.008), tumor size (p=0.022), T stage (p=0.004), neutrophil count (p&lt;0.001), lymphocyte count (p&lt;0.001), recurrence at follow-up (p=0.006). Preoperative PLR was significantly correlated with symptom presentation (p&lt;0.001), lymphocyte count (p&lt;0.001), recurrence at follow-up (p=0.002). In the univariate analysis, clinical presentation, tumor size, T stage, Fuhrman grade, preoperative hemoglobin, neutrophil count, NLR, PLR were significant prognostic factors for recurrence-free survival. The 5-year recurrence-free survival rate of patients with a higher preoperative NLR (≥2.5) was significantly lower than that of patients with a lower preoperative NLR (&lt;2.5) (86.5% vs. 96.7%, p=0.006). The 5-year recurrence-free survival rate of patients with a higher preoperative PLR (≥130) was significantly lower than that of patients with a lower preoperative PLR (&lt;130) (89.4% vs. 96.8%, p=0.022). In the multivariate analysis, tumor size (p&lt;0.001), T stage (p&lt;0.001), Fuhrman grade (p=0.015) and preoperative hemoglobin (p=0.026) were independent prognostic factors for recurrence-free survival. 

Conclusions: An increased preoperative NLR and PLR were associated with a higher recurrence rate in patients with non-metastatic clear cell RCC, although it was not an independent prognostic factor for recurrence-free survival.</dc:description>
<dc:description>Ⅰ. INTRODUCTION 1 

Ⅱ. MATERIALS AND METHODS 2 

Ⅲ. RESULTS 3 

Ⅳ. DISCUSSION 11 

Ⅴ. CONCLUSION 13 

REFERENCES 14 

국문요약 18</dc:description>
<dc:description>Master</dc:description>
<dc:date>2015-11-02</dc:date>
<dc:date>2015-11-02</dc:date>
<dc:date>2015</dc:date>
<dc:date>2015</dc:date>
<dc:type>Thesis</dc:type>
<dc:type>Theses</dc:type>
<dc:identifier>http://repository.ajou.ac.kr/handle/201003/11871</dc:identifier>
<dc:identifier>http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000020339</dc:identifier>
<dc:identifier>000000020339</dc:identifier>
<dc:language>en</dc:language>
</oai_dc:dc>
</metadata></record></GetRecord></OAI-PMH>